https://scholars.lib.ntu.edu.tw/handle/123456789/624848
標題: | MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma | 作者: | Wang W.-G Liu Z.-B Jiang X.-N Lee J Zhou X.-Y Li X.-Q. LI-HSING LEE |
關鍵字: | B-cell receptor; diffuse large B-cell lymphoma; MYC | 公開日期: | 2017 | 卷: | 71 | 期: | 5 | 起(迄)頁: | 778-785 | 來源出版物: | Histopathology | 摘要: | Aims: MYC overexpression is a common feature of diffuse large B-cell lymphoma (DLBCL) and is associated with poor prognosis in patients with this neoplasm. We aimed to investigate the underlying mechanisms of MYC dysregulation, as they have not been fully determined. Methods and results: We immunohistochemically evaluated the correlation between B-cell receptor (BCR)–phosphoinositide 3-kinase (PI3K) pathway activity and MYC level in 108 cases of de-novo DLBCL, 25 of which featured loss of BCR, and investigated the effects of BCR–PI3K signalling on MYC level and phosphorylation in DLBCL cell lines. The expression levels of phospho-SYK and phospho-AKT correlated with MYC expression in BCR-positive DLBCL. MYC expression was significantly lower in BCR-negative tumour tissues than in BCR-positive tumour tissues. Upon BCR stimulation, the BCR-positive cell lines showed active BCR–PI3K signalling and decreased MYC phosphorylation at T58, leading to an increased overall level of MYC. Conversely, inhibition of BCR–PI3K signalling increased MYC phosphorylation and thus resulted in a decreased overall level of MYC. No effects were observed in the BCR-negative cell lines. Conclusions: Overexpression of MYC in DLBCL can be driven by the BCR–PI3K signalling pathway via dephosphorylation at T58, and BCR inhibitors may exert their functions by down-regulation of MYC. © 2017 John Wiley & Sons Ltd |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029440365&doi=10.1111%2fhis.13287&partnerID=40&md5=1c8c4b2b8d343fe3fede62d69a9b0a5e https://scholars.lib.ntu.edu.tw/handle/123456789/624848 |
ISSN: | 03090167 | DOI: | 10.1111/his.13287 | SDG/關鍵字: | B lymphocyte receptor; Myc protein; phosphatidylinositol 3 kinase; BCR protein, human; breakpoint cluster region protein; lymphocyte antigen receptor; Myc protein; MYC protein, human; phosphatidylinositol 3 kinase; adult; aged; Article; controlled study; diffuse large B cell lymphoma; female; flow cytometry; human; human cell; immunohistochemistry; immunophenotyping; in vitro study; major clinical study; male; priority journal; protein dephosphorylation; protein depletion; protein expression; protein phosphorylation; retrospective study; diffuse large B cell lymphoma; metabolism; middle aged; pathology; physiology; signal transduction; very elderly; young adult; Adult; Aged; Aged, 80 and over; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcr; Proto-Oncogene Proteins c-myc; Receptors, Antigen, B-Cell; Retrospective Studies; Signal Transduction; Young Adult |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。